Hualan Biological Engineering Inc.

SZSE:002007 株式レポート

時価総額:CN¥30.0b

Hualan Biological Engineering 将来の成長

Future 基準チェック /36

Hualan Biological Engineering is forecast to grow earnings and revenue by 20.3% and 18.5% per annum respectively. EPS is expected to grow by 20.3% per annum. Return on equity is forecast to be 12.6% in 3 years.

主要情報

20.3%

収益成長率

20.3%

EPS成長率

Biotechs 収益成長44.8%
収益成長率18.5%
将来の株主資本利益率12.6%
アナリストカバレッジ

Good

最終更新日01 Nov 2024

今後の成長に関する最新情報

Recent updates

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 36% Below Their Intrinsic Value Estimate

Oct 07
Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 36% Below Their Intrinsic Value Estimate

Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Aug 22
Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jun 26
Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

Jun 09
Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Jun 07
These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

May 21
Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Feb 27
Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

業績と収益の成長予測

SZSE:002007 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20267,3552,0542,3241,90711
12/31/20256,3901,7702,4761,71713
12/31/20245,1491,3581,6272,3966
9/30/20244,9201,3384361,113N/A
6/30/20245,4091,395256900N/A
3/31/20245,2491,3923461,027N/A
12/31/20235,3421,4825921,346N/A
9/30/20234,8281,2438071,538N/A
6/30/20233,7531,0201,0991,713N/A
3/31/20234,7571,1948351,268N/A
1/1/20234,5171,076563957N/A
9/30/20224,6771,139136662N/A
6/30/20225,4971,42554704N/A
3/31/20224,4531,2774741,225N/A
1/1/20224,4361,2996211,432N/A
9/30/20215,3111,7091,0161,642N/A
6/30/20214,9251,5599071,594N/A
3/31/20214,9691,6217641,495N/A
12/31/20205,0231,6137041,325N/A
9/30/20204,1341,2846081,166N/A
6/30/20203,6841,2889021,295N/A
3/31/20203,6821,2719531,271N/A
12/31/20193,7001,2831,0901,363N/A
9/30/20193,8191,3441,0881,334N/A
6/30/20193,4181,1941,2141,451N/A
3/31/20193,3511,1921,2551,440N/A
12/31/20183,2171,1401,1091,293N/A
9/30/20182,738961746864N/A
6/30/20182,556843N/A590N/A
3/31/20182,392773N/A308N/A
12/31/20172,368821N/A177N/A
9/30/20172,195792N/A146N/A
6/30/20172,091801N/A120N/A
3/31/20172,061843N/A203N/A
12/31/20161,935780N/A330N/A
9/30/20161,767737N/A443N/A
6/30/20161,671690N/A585N/A
3/31/20161,585632N/A549N/A
12/31/20151,472589N/A549N/A
9/30/20151,386575N/A501N/A
6/30/20151,372563N/A429N/A
3/31/20151,263514N/A429N/A
12/31/20141,243538N/A497N/A
9/30/20141,237547N/A541N/A
6/30/20141,141530N/A501N/A
3/31/20141,104519N/A503N/A
12/31/20131,118475N/A511N/A

アナリストによる今後の成長予測

収入対貯蓄率: 002007's forecast earnings growth (20.3% per year) is above the savings rate (2.9%).

収益対市場: 002007's earnings (20.3% per year) are forecast to grow slower than the CN market (25.8% per year).

高成長収益: 002007's earnings are expected to grow significantly over the next 3 years.

収益対市場: 002007's revenue (18.5% per year) is forecast to grow faster than the CN market (14% per year).

高い収益成長: 002007's revenue (18.5% per year) is forecast to grow slower than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 002007's Return on Equity is forecast to be low in 3 years time (12.6%).


成長企業の発掘